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Deconstructing the interaction of
glu-plasminogen with its receptor
-enolase
N. M. Andronicos1, M. S. Baker2, M. Lackmann3, M. Ranson1
1

Department of Biological Sciences, University of Wollongong, NSW, 2522, Australia 2Gynaecological Cancer Research
Centre and Department of Obstetrics and Gynaecology, University of Melbourne, Royal Women’s Hospital, Carlton, Victoria,
Australia 3Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, Victoria, Australia

Summary Objective: Plasminogen binds with apparent low-affinity to cell-surface receptors via its lysine binding sites.
This enhances/stabilizes the activation-susceptible conformation. However, it is not known whether this lysine-mediated
conformational change of plasminogen may affect its subsequent dissociation rate and hence its stability at the cell
surface. Therefore, we sought to determine the relationship between the lysine-dependent conformation of plasminogen and its dissociation rate from its receptor.
Design: BIACORE experiments were used to determine the kinetics of the interaction of glu-plasminogen with its
receptor ␣-enolase. Intrinsic and extrinsic fluorescence spectroscopy were utilized to confirm if ␣-enolase induced a
conformational change to glu-plasminogen as predicted by analyses of the BIACORE data.
Results: The dissociation of glu-plasminogen from ␣-enolase was mediated by at least two components with apparent
dissociation rate constants of kd1:4.71092 s91 and kd2:1.61093 s91. This second slower dissociation event
reflects an increase in the stability of the complex. Global analysis of the interaction suggested a two-state conformational change reaction, mediated by a concentration-dependent increase in the initial association rate constant. The
apparent Kd predicted by this analysis was 1M. Fluorescence spectroscopy confirmed that ␣-enolase induced a more
open conformation of glu-plasminogen.
Conclusions: These results provide direct evidence that the binding of glu-plasminogen to ␣-enolase is not simply a lowaffinity interaction, but involves a multivalent, competition binding reaction that is associated with a glu-plasminogen
conformational change. This mechanism is compatible with the structure of glu-plasminogen. This has implications for
the stability of binding and activation of glu-plasminogen at the cell surface. © 2000 Harcourt Publishers Ltd

INTRODUCTION
Plasmin is responsible for a wide variety of physiological
and pathological processes which involve the breakdown of tissue barriers and cell migration. Plasmin, a
trypsin-like broad spectrum serine endopeptidase, is generated from the zymogen glu-plasminogen (glu-plg)
which is abundant ( present at approximately 2 M) in
plasma.1 Human glu-plg1 (EC 3.4.21.7) is a single chain
790 amino-acid glycoprotein that has an apparent molecular weight of 92 kDa.1 Glu-plg is composed of both a
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heavy chain (65 kDa), containing the N-terminal peptide
(NTP) and five triple-disulfide-bonded kringle (K)
domains, and a light chain (25 kDa) or protease domain
chain.1 The crystal structures of the individual K1,2 K43,4
and K55 of plg have been solved and demonstrate that
the lysine binding site (LBS) motifs are pre-formed and
localized to the surfaces of the kringle domains. Glu-plg
exhibits a closed, right-handed, spiral conformation.6–8
Removal of NTP from glu-plg results in the formation of
lys-plg (86 kDa)9 which has a more open, U-shaped conformation than glu-plg.10,11
Site-directed mutagenesis studies, which removed the
lysine binding function of individual kringle domains,
have demonstrated that the closed conformation of gluplg is maintained by the binding of multiple kringle LBS
motifs with internal lysine residues12,13 such as Lys50 and
1

2
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Lys62 located in the NTP of glu-plg.13 The presence of this
intramolecular lysine-binding network suggests the LBS
motifs of glu-plg are occupied by the internal lysine
residues of the protein. Disruptions to the intramolecular
lysine binding network of glu-plg by exogenous lysine
analogues induces an open conformation of glu-plg. The
interactions of lysine analogues at multiple sites within
glu-plg change the conformation of the protein from its
closed to open state.14,15 This conversion is not accompanied by a change in the secondary structure of glu-plg,16,17
but is dependent upon the interactions of the kringle
domains with lysine residues. Christensen and Molgaard18
demonstrated that a rapid conformational change of gluplg (t1/2:0.01 s) is mediated by the cooperative binding of
the LBS motifs of K5 and K4 to the small lysine analogue
-amino caproic acid (-ACA).19 Marshall et al.10 suggested
that glu-plg can actually exist in three distinct conformations in vitro; ␣ (closed), ␤ (partially open), and ␥ (fully
open). Incubation of glu-plg ␣ with the K5 specific ligand,
benzamidine,20 induces the formation of glu-plg ␤.10
Subsequent treatment of glu-plg ␤ with -ACA induces
the formation of glu-plg ␥,10 confirming that the cooperative interaction between K5 and another LBS is responsible for inducing the fully open conformation of glu-plg.
The binding of small lysine analogues to glu-plg
changes the conformation to a form that is susceptible
to activation by the plg activators.14,15,21–23 The activation of glu-plg is also enhanced by a lysine-dependent
interaction with macromolecules such as fibrin,24 various cell types,25,26 and isolated cellular plg receptors
such as ␣-enolase.27,28 Several studies, including our
own,26,27 have utilized various end-point assays to study
the interaction of glu-plg with both cells and cellular plg
receptor molecules.27,28 These studies have provided
information on binding parameters such as affinity and
binding capacity (in the case of intact cells), however,
the type of binding kinetics of glu-plg have not been
determined. We, therefore, used BIACORE technology to
characterize in real-time the relationship between binding and conformational switching of glu-plg using
recombinant ␣-enolase as a model receptor.27 Furthermore, fluorescence spectroscopy was used to confirm
␣-enolase-induced conformational changes in glu-plg
observed by BIACORE analysis. In addition, we attempted
to analyze the type of binding kinetics lys-plg undergoes
using BIACORE technology under identical conditions to
those used for glu-plg. We reasoned that since lys-plg
has a more open conformation than glu-plg,10,11 by comparing the binding kinetics between the two plg forms,
we would gain additional insights into the binding
mechanism of glu-plg. The results presented here provide
direct evidence that the binding of glu-plg to ␣-enolase
involves a multivalent, competition binding reaction that
is associated with a conformational change in glu-plg.
Fibrinolysis & Proteolysis (2000) 0(0), 1–10

The implications of these data will be discussed in terms
of the activation of glu-plg.
MATERIAL AND METHODS
Recombinant human hexa-histidine-tagged ␣-enolase was
purified as previously described27 and will be referred to
as ␣-enolase throughout the text. Human plasmin, gluand lys-plg were generous gifts from Dr Richard Hart,
American Diagnostica Inc. (Greenwich, CT, USA). Glu-plg
was labelled with fluorescein isothiocyanate (FITC) as
described previously.26
BIACORE binding assays
The binding of glu-plg to recombinant ␣-enolase was
analyzed on the BIACORE optical biosensor (Pharmacia
Biosensor, Sweden) using either ␣-enolase-(His)6-derivatized CM 5 or NTA-modified sensor chips. Covalent
immobilization of ␣-enolase onto N-hydroxysuccinimide
(NHS, 0.05 M)/N-hydroxysuccinimide-N-ethyl-N⬘-(diethylaminopropyl)carbodiimide (0.2 M) – activated sensor
chips was performed essentially as described.29 Prior to
analysis, plg was buffer exchanged (Phast-desalting
column, 1003.2 mm, Amersham-Pharmacia) into
BIACORE running buffer (10 mM Hepes, 150 mM NaCl,
1.4 mM EDTA, 0.005% Tween-20, pH 7.4) and adjusted
to a concentration of 10 M. From this stock solution,
dilutions were prepared for BIACORE experiments. The
affinity surface was regenerated between subsequent
sample injections of plg with 35 l of a desorption buffer
(3 M MgCl2, 0 . 0 7 5 M Hepes/NaOH, 25% ethylene
glycol, pH 7.2) followed by two washes with BIACORE
running buffer. Alpha-enolase (His)6 (15 l, 200 nM) was
also bound onto a NTA-modified sensor chip (BIACORE
AB, Sweden) which had been charged with an injection
of 25 l NiCl2 (0.5 mM) in modified running buffer containing 50 M EDTA. In these experiments the chip surface
was regenerated after sample application by sequential
15 l-injections of 6 M guanidine-hydrochloride, 50 mM
EDTA, 20 mM Tris-HCl (pH 8.6) and of 0.35 M EDTA,
0.15M NaCl, 0.005% Tween 20 (pH 8.2). To minimize differences in the ␣-enolase concentration on the chip surface, injection of both NiCl2 and ␣-enolase (His)6 from
the same NiCl2 and ␣-enolase stock solutions were used
for all experiments.
Analysis of BIACORE sensorgram data
BIACORE sensorgram data were fitted as described previously30 to the reaction models included in the BIAevaluation software. Briefly, a minimum of six data sets
corresponding to plg binding reactions at concentrations
between 4 M and 63.5 nM were analyzed. Fitting the
© Harcourt Publishers Ltd 2000
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sensorgram data to the algorithms of reaction schemes
1 and 2 involved analyzing the individual association or
dissociation phases of each binding reaction using the
BIAevaluation software, version 3.0. The global fit modeling of reaction schemes 3–5 involved the simultaneous
fitting of the association and dissociation phases of the
individual binding reactions.
Both the 2-statistical test and the distribution of the
residuals were used to determine whether a particular
reaction scheme was a good mathematical representation of the plg binding sensorgram data. Theoretical
models that displayed small 2 values and which did not
vary by a large magnitude over the range of plg concentrations examined, were deemed to be a good mathematical representation of the sensorgram data. Deviations of
the sensorgram data from a theoretical reaction scheme
model that had small 2 statistics had to also have small
and random deviation from the sensorgram data (residuals), since the magnitude and distribution of these residuals demonstrates the quality of the sensorgram data.
Reaction scheme 1
A;B ↔ AB: a simple 1 : 1 Langmuir kinetic.



Reaction scheme 2
Ai;Bi ↔ AiBi: a two or more component dissociation
kinetic model, confined to the estimation of the dissociation rates for each of the components of the interaction since knowledge of the analyte (plg)
concentrations that contribute to its interaction with
ligand (␣-enolase) are not required.

3

room temperature. Plg species (1M) in 50 mM Tris-HCl
(pH 7.0), 100 mM NaCl were excited at 280 nm and the
intrinsic fluorescence emission spectra were measured
from 300–450 nm.
Extrinsic fluorescence spectroscopy
All FITC-plg fluorescence studies were performed using
a Biolumin 960 (Molecular Dynamics) fluorescent plate
reader equipped with a FITC set of filters (excitation: 480<10 nm; emission: 520<10 nm). FITC-glu-plg
(10 g/ml) in 50 mM Tris-HCl (pH 7.2), 150 mM NaCl was
incubated with various concentrations of either tranexamic acid (0–20 mM), poly-D-lysine (0–2.5 mg/ml) or
␣-enolase (0–40 g/ml) in a total volume of 200 l for
5 min in the dark at room temperature. The fluorescence
intensity data were normalized by calculating the
change in fluorescence percentage of FITC-glu-plg (⌬F%).
The fractional saturation (y) was calculated using the
equation: (FI-F)/(FI-Ff), where FI is the initial fluorescence
of FITC-glu-plg in the absence of ligand, Ff is the fluorescence of FITC-glu-plg at the maximal ligand concentration used and F is the fluorescence associated with a
specific concentration of ligand.



Reaction scheme 3
A;B ↔ AB ↔ A*B: the two-state reaction/conformational change model – analyte (A:plg) binds to ligand (B:␣-enolase). Complex AB changes to A*B
which cannot dissociate directly to A;B without first
undergoing the reverse conformational change.



Reaction scheme 4
 A;B1 ↔ AB1; A;B2 ↔ AB2: heterogeneous ligand
(B:␣-enolase), parallel interactions – one analyte
(A:plg) binds independently to two ligand binding
sites (B1, B2). Two independent sets of rate constants,
ka1, kd1 and ka2, kd2.
Reaction scheme 5
 A;B ↔ AB; AB;B ↔ AB2: bivalent analyte A (plg)
binds to a monovalent ligand B (␣-enolase).
Intrinsic fluorescence spectroscopy
All fluorescence experiments were performed using a
F4500 Fluorimeter (Hitachi) with a slit width of 5 nm at
© Harcourt Publishers Ltd 2000

RESULTS
Dissociation kinetics of glu- and lys-plg from
immobilized ␣-enolase
This study describes for the first time the dissociation
kinetics of glu- and lys-plg from sensor chip-immobilized
␣-enolase. The BIACORE sensorgrams (binding curves)
obtained from the binding of increasing concentrations
of glu- and lys-plg to NHS-immobilized ␣-enolase are
shown in Figure 1. A qualitative assessment of the sensorgrams reveals obvious differences in the interaction
of glu-plg (Fig. 1A) and lys-plg (Fig. 1B) binding with
␣-enolase. This was most evident in the contours of their
apparent steady-state phases (between arrow I and II)
which did not result in equilibrium binding under these
experimental conditions. Importantly, the contour of the
sensorgrams suggested a heterogeneous interaction for
both glu- and lys-plg with ␣-enolase.
By comparing the fit of the experimental data to different kinetic algorithms available in the BIAevaluation
software, we set out to establish a suitable kinetic model
for the observed binding data (Table 1). The linear oneto-one pseudo-first order model (Reaction scheme 1) did
not fit the data, as indicated by a pronounced decrease
in the ‘goodness of fit’ 2 (increase of 2 above the ‘signal
noise’ of 3 – 6 RU) with increasing plg concentrations
(Table 1), and by a marked deviation of the ‘offset values’ (deviation of the fitted response at t :⬁) from zero
Fibrinolysis & Proteolysis (2000) 0(0), 1–10
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Fig. 1 BIACORE analysis of glu- and lys-plg binding to
NHS-immobilized ␣-enolase. (A) Samples containing increasing
concentrations of glu-plg in BIACORE running buffer were injected
onto a sensor chip which had been derivatized with immobilized
␣-enolase using NHS/EDC chemistry. The decreasing responses
reflect samples containing 4, 3, 2, 1, 0.5, 0.25, 0.125, 0.0625 M
glu-plg. Arrows marked with I and II indicate the start and end of the
sample injection (start of association and dissociation phases)
respectively. (B) The response curves for the interaction of varying
concentrations of lys-plg with the sensorchip-immobilized ␣-enolase
are shown. Coupling of ␣-enolase and concentration of lys-plg were
according to the conditions described in A.

(not shown). Similarly, the concentration-dependent
increase of 2 values in the fit of association data to the
single component model confirms that the interaction
cannot be described adequately by this model. In contrast, the multiple component dissociation model (reaction scheme 2), which does not require knowledge of the
concentration of plg, produced an accurate fit to the dissociation data and yielded 2 values close to zero (Table 1)
as well as small random residuals for all concentrations
of glu- and lys-plg analyzed. Statistical comparison of the
fits (2 values) to the two models by F-test confirmed
that the multiple component model is a better mathematical representation of these data, since F-test values
Fibrinolysis & Proteolysis (2000) 0(0), 1–10

of 1.0 were obtained for both glu- and lys-plg binding.
Thus, the dissociation of glu- and lys-plg from ␣-enolase
was mediated by at least two reactions.
Both glu- and lys-plg had similar, apparently rapid (low
affinity) dissociation rate constants (kd1:4.71092 s91
and 4.01092 s91 respectively) from NHS-immobilized
␣-enolase (Table 1). While the slow dissociation rate
constant (higher affinity) component of lys-plg (kd2:
6.31094 s91) was twofold lower compared to that of
glu-plg (kd2:1.61093 s91) (Table 1), it was clear that
both glu- and lys-plg interacted with ␣-enolase via at
least two distinct binding sites. In addition, -ACA competitively disrupted the binding of glu- and lys-plg to
NHS-immobilized ␣-enolase (data not shown), confirming the role of lysine in these interactions.27,28 Similar
binding experiments were also performed using a sensor
chip with substantially less NHS-immobilized ␣-enolase
(1.3 ng/mm2 versus 4.3 ng/mm2 immobilized). Whilst the
overall responses were reduced, very similar binding
characteristics were observed (data not shown). This
indicated that the kinetics were not effected by masstransfer limitations during the interactions of glu- and
lys-plg on the more densely derivatized sensor chip.
The kinetics of the interaction between plg and ␣-enolase were also analyzed using ␣-enolase that was immobilized in a defined orientation via its N-terminal
6-Histidine tag. This was done to determine if the random orientation of ␣-enolase contributed to the multiple
component kinetics of the interaction. Sensorgram binding curves, similar to those reported in ure 1, were
observed for both glu- and lys-plg binding, and a representative set of glu-plg sensorgrams are shown in
Figure 2. The estimated dissociation rate constants (kd1:
6.11092 s91 and kd2:11093 s91) were also comparable to those obtained for the binding of glu-plg to
NHS-immobilized ␣-enolase (Table 1). Thus, the multiple
component dissociation reaction model (Reaction
scheme 2) best approximated the dissociation phase of
glu- and lys-plg interaction with ␣-enolase.
␣-enolase binding data
Global fitting of the plg/␣
Global fitting of the BIACORE binding data was performed in order to further define the interaction mechanisms. The entire binding data describing the plg/
␣-enolase interaction at different plg concentrations
were fitted to a number of kinetic algorithms, including
linear one-to-one interaction and several complex interaction models. The selected kinetic model(s) were then
used to simultaneously analyze the kinetic parameters of
the association and dissociation phases of the individual
plg/␣-enolase binding curves (Tables 2 & 3). The probability of an appropriate fit of the experimental data to
the selected model are also shown in Tables 2 and 3.
© Harcourt Publishers Ltd 2000
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Table 1

Kinetic analysis of the interaction of glu-plg with ␣–enolase from the BIACORE sensorgrams

Experiment

Glu-Plasminogen (NHS3)
(goodness of fit (2)
Lys-Plasminogen (NHS3)
(goodness of fit (2)
Glu-Plasminogen (NTA4)
(goodness of fit (2)
1

2

3

4

5

Kinetic constants
Single component
(A;B↔ÁB)1
ka (M91s91)
2.8104
(0.054–7.51)
3.4105
(0.088–7.35)
4.1104
(0.05–15.8)

kd (s91)
3.21093
(0.073–88.2)
4.01093
(3.29–83.2)
1.41093
(0.102–13.7)

Kinetic constants
Single component
(Ai;Bi ↔ ÁiBi)2
kd1 (s91)
kd2(s91)
4.71092
1.61093
(0.0203–0.060)
4.01092
6.31094
(0.0389–0.112)
6.11092
1.01093
(0.015–0.061)

Association and dissociation rate constants derived from progress data of the BIACORE sensorgrams
using linear kinetic models included in the BIAevaluation software, R:Req(19e9(kaC;kd)(t9t0)), where Req
is the steady state response (R) which is not necessarily reached in the sensorgram, C:molar
concentration, t0:start time of sensorgram. The time interval for the analysis of the association rate
constants were 138 s–165 s (Figs 1 & 2). The time interval for the analysis of the dissociation rate
constants were 695 s–750 s (Figs 1 & 2).
Dissociation rate constants for two parallel dissociation reactions were estimated according to
R:R1e9kd1(t9t0);(R09R1)e9kd2(t9t0), where R1 and R09R1 are the contributions to R0 from component
1 and 2 respectively (Figs 1 & 2).
Experiments on a CM-5 sensor chip derivatized with enolase using NHS/EDC chemistry to yield an
increase in the baseline response of 3900 RU. Following each cycle the chip surface was regenerated by
desorption of non-covalently bound protein with a MgCl2/ethylene glycol buffer (see methods) (Fig. 1).
Experiments on a Ni-NTA-derivatized sensor chip carrying ␣-enolase coupled by its N-terminal 6-his
affinity tag to yield an increase of 1800 RU above baseline. Following each cycle ␣-enolase together with
the Ni2; was stripped from the NTA-chip with GnHCl/EDTA (see methods) and the chip re-charged with
Ni2; and loaded with ␣-enolase (Fig. 2).

Fig. 2 BIACORE analysis of glu-plg binding to Ni2;-NTA
immobilized ␣-enolase. ␣-enolase was immobilized onto a Ni2;NTA chip by its N-terminal 6-his affinity tag. The decreasing
responses reflect samples containing 4, 3, 2, 1, 0.5, 0.25, 0.125
and 0.0625 M glu-plg. Following each injection of glu-plg, bound
ligand, Ni2; and ␣-enolase were stripped from the NI2;-NTA-chip
and the affinity surface regenerated by the injection of Ni2; and
␣-enolase prior to the injection of glu-plg (see methods). The
sensorgrams presented only show the progress data for the
injection of glu-plg (arrow I) and its dissociation (arrow II) from the
␣-enolase surface.

The two-state reaction/conformational change model
(Reaction scheme 3) yielded a good fit within the range
of glu-plg concentrations examined (2: 0.992.2; Table 2;
© Harcourt Publishers Ltd 2000

small random residuals). As suggested by the contour
of the binding curves, the interaction of glu-plg with
␣-enolase was characterized by an initial apparent fast
dissociation rate constant (kd1:2.64<0.61092 s91) and
an association rate constant which was increasing
with decreasing glu-plg concentrations (ka1:4.3919.3
103 M91 s91). In contrast, the second phase of the interaction appeared to proceed in a largely concentrationindependent manner with markedly lower on and off rates
(ka2:3.81093 M91 s91 and kd2:7.4<0.271094 s91).
Overall, the dissociation rate constants, derived by fitting
the glu-plg binding data to this model (Reaction scheme
3), were comparable to the rate constants estimated by
the multiple component dissociation reaction (Reaction
scheme 2) discussed earlier (Table 1). Furthermore, the
apparent Kd (Table 2) are comparable to the values
derived using other techniques.27,28 Thus, the interaction
of glu-plg with ␣-enolase may result in a conformational
change to glu-plg such that it cannot dissociate from
␣-enolase without undergoing another conformational
change.
An alternative model, assuming a heterogeneous population of sensor chip-immobilized ␣-enolase binding
glu-plg in parallel reactions (Reaction scheme 4) yielded
a markedly decreased fit with 2 values between 1.9 and
141 (Table 2). Thus, the heterogeneous ␣-enolase reaction model (Reaction scheme 4) did not adequately
represent the data. Similarly, global analysis with an
algorithm which adjusts for mass transfer limitations of
the analyte (plg) binding to a sensor surface of high ligand
Fibrinolysis & Proteolysis (2000) 0(0), 1–10
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Table 2

Kinetic parameters of the glu-plg/␣-enolase interaction

Concentration
M

Kd
M

4
3
2
1
0.5
0.25
Mean2

1.5
1.4
1.05
0.6
1.5
0.2
1.0

1

2

M s
(1093)
4.3
5.0
6.3
8.6
11.9
19.3

Kd1
s91
(1092)
3.5
3.26
2.8
2.2
2.0
2.1
2.64

M s
(1093)

Kd2
s91
(1094)

2
Two-state-reaction1

2
Heterogeneous
ligand1

4.5
4.3
4.1
4.2
2.8
2.6
3.8

8.0
9.3
9.7
9.6
2.6
5
7.4

2.0
2.2
2.0
1.1
0.9
0.9

141
22.1
26.5
23.9
4.94
1.9

Ka2
91 91

The binding data were fitted to the two kinetic algorithms of the BIAevaluation 3.0 software (see methods) which
yielded the closest match of experimental data with the chosen model. The listed kinetic constants are derived in each
case only from the candidate model with the closest fit (lowest 2 value).
Mean values were estimated only for those parameters which did not indicate a concentration-dependent change.

Table 3

Kinetic parameters of the lys-plg/␣-enolase interaction

Concentration
M
4
3
2
1
0.5
0.25
0.125
1

Ka1
91 91

Kd
M

Ka1
M91s91
(104)

Kd1
s91
(1092)

Ka2
M91s91

Kd2
s91
(1093)

3.2
2.6
0.8
0.9
Kd1: 3.5
Kd1: 1.9
Kd1: 0.8

2.0
2.4
2.6
3.8
1.9
2.7
5.9

7.6
7.6
6.6
5.5
6.6
5.3
4.5

3.31093
3.21093
2.61093
1.81093
6.61097
7.81097
19.51097

2.7
2.6
0.9
1.2
1.1
1.0
1.2

2
Two-state-reaction1

48.3
24.7
15.8
41.1
363
320
193

2
Bivalent
analyte1
121
475
112
1240
8.79
3.42
1.96

The binding data were fitted to the two kinetic algorithms of the BIAevaluation 3.0 software (see methods) which
yielded the closest match of experimental data with the chosen model. The listed kinetic constants are derived in each
case only from the candidate model with the closest fit (lowest 2 value).

(i.e. ␣-enolase) concentration resulted in a poor fit to the
glu-plg sensorgram data (data not shown), confirming
that these effects did not influence the kinetics of the
interaction.
In contrast to glu-plg, the generally large 2 values
obtained for the lys-plg binding data indicated that none
of the global fitting models currently available fitted the
data over the entire lys-plg concentration range used
(Table 3). As stated above, the multiple component
model (Reaction scheme 2) is determined independently
of the association phases and provided a strong fit of the
lys-plg dissociation data (Table 1). Since the dissociation
rate constants shown in Table 3 were similar to those
obtained by the multiple component model (Reaction
scheme 2) for the same range of lys-plg concentrations
(Table 1), it is possible that the association phase is the
component of the binding interaction that cannot be
deconvoluted by any of the global fitting algorithms currently available, at least under the physiological-like conditions used in these experiments. In any case, it is clear
that glu- and lys-plg have different binding mechanisms
with respect to ␣-enolase.
Fibrinolysis & Proteolysis (2000) 0(0), 1–10

Intrinsic fluorescence spectroscopy
To qualitatively confirm that binding with ␣-enolase
induces a conformational change in glu-plg, the intrinsic
fluorescence spectra of glu-plg in the presence and
absence of ␣-enolase were determined (Fig. 3). These
were compared to the intrinsic fluorescence spectra of
glu-plg in the presence and absence of the lysine analogue -ACA, previously shown to ‘open’ glu-plg resulting in an increase in its intrinsic fluorescence.19 In
addition, the spectra of plasmin and lys-plg, which have
a more open conformation than glu-plg,10,11 are shown
for comparison.
Plasmin and lys-plg had comparable relative intrinsic
fluorescence emission maxima at 330 nm (4850 and
4694 respectively). In contrast, the relative intrinsic fluorescence maximum for glu-plg was significantly lower
(3480). Addition of -ACA to glu-plg (Fig. 3A) resulted in
an increase in the relative intrinsic fluorescence of gluplg (⌬F:1019) to one which was comparable to the relative fluorescence obtained for the same concentration of
either lys-plg or plasmin. The addition of ␣-enolase to
© Harcourt Publishers Ltd 2000
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Fig. 3 Comparison of the intrinsic fluorescence spectra of glu-plg
in the absence and presence of -ACA or ␣-enolase to those of
plasmin and lys-plg. (A) The fluorescence spectra of 1 M plasmin,
glu- and lys-plg, glu-plg;100 mM -ACA and 100 mM -ACA
control were obtained after excitation at 280 nm. (B) The
fluorescence spectra of 1 M plasmin, glu- and lys-plg, gluplg;190 nM ␣-enolase and 190 nM ␣-enolase control were
obtained after excitation at 280 nm. The intrinsic fluorescence
spectra of both -ACA (117) and ␣-enolase (146) at the
concentrations used for these experiments were negligible. Higher
concentrations of ␣-enolase could not be used as this alone was
associated with increased intrinsic fluorescence (data not shown).

glu-plg (Fig. 3B) also induced an increase in the relative
intrinsic fluorescence of glu-plg (⌬F:785) which was
suggestive of a conformational change.
Extrinsic fluorescence spectroscopy
The disadvantage of using the intrinsic fluorescence
method is that higher concentrations of ␣-enolase than
those used in Figure 3 contributed to the intrinsic fluorescence of the system (data not shown). Therefore, reliable titration curves could not be obtained. To overcome
this problem, the change in fluorescence associated with
© Harcourt Publishers Ltd 2000
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FITC-labelled glu-plg was measured in the presence of
various concentrations of ␣-enolase (Fig. 4C). In addition,
various concentrations of two other plg binding ligands
namely, tranexamic acid and poly-D-lysine were also
used for comparison (Figs 4A & B). All of the ligands
increased the fluorescence of FITC-glu-plg such that the
maximal ligand-induced change observed was between
7 and 10% of the total fluorescence of FITC-glu-plg
(⌬/F%; Fig. 4). These were comparable in magnitude to
the reported fluorescence changes induced by small
lysine analogues on glu-plg.19 The maximal fluorescence
changes in FITC-glu-plg were induced by molar excesses
of ligand. For example, molar ratios of greater than 5 : 1
of ␣-enolase to FITC-glu-plg (i.e. greater than 20 g/ml of
␣-enolase) were required to approach maximal fluorescence changes (Fig. 4C). These fluorescence data suggest
that ␣-enolase can induce a conformational change in
glu-plg thereby confirming Reaction scheme 3 as a
viable model for the binding of glu-plg to ␣-enolase.
Hill plots were utilized to determine the type of conformational change that these ligands induced in FITCglu-plg. The slope of the Hill plot (Fig. 4A, inset) that
describes the binding of tranexamic acid to FITC-glu-plg,
was approximately 1.5. This result confirmed the observations of Christensen and Molgaard,19 that the binding
of tranexamic acid to glu-plg is associated with a cooperative conformational change. Similarly, the interaction of
poly-D-lysine with FITC-glu-plg resulted in a Hill coefficient greater than 1 (i.e. approximately 1.5; Fig. 4B, inset)
suggesting that glu-plg binds cooperatively to poly-Dlysine. The binding of FITC-glu-plg to ␣-enolase resulted
in a Hill coefficient of 1.02 (Fig. 4C, inset) suggesting
that the interaction was not a cooperative process.
DISCUSSION
This study aimed to define the type of binding kinetics
and associated conformational changes glu-plg undergoes when it binds to its cellular receptor, ␣-enolase.
Experiments were performed using BIACORE technology
under physiological-like conditions and analyzed using
BIAevaluation software (version 3.0). Identical experiments were performed with lys-plg for direct comparison
with glu-plg on the basis that lys-plg has a more open
conformation and is more readily activated.10,31 This is a
feature of lys-plg exploited in numerous studies that
have compared conformational status with the activation of the different plgs, both in solution and in the
presence of binding moieties (reviewed in 31), as well as
with their binding parameters.
The simplest reaction model describing the lysinedependent dissociation phases of both the glu- and lysplg sensorgrams is the non-linear multiple component
dissociation model (Reaction scheme 2). Glu-plg has also
Fibrinolysis & Proteolysis (2000) 0(0), 1–10
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Fig. 4 Normalized fluorescence emission intensities (⌬F%) obtained after the interaction of FITC-glu-plg with various concentrations of (A)
tranexamic acid, (B) poly-D-lysine and (C) ␣-enolase, plotted against the concentrations of these ligands. The inset shows a Hill plot for each
of the ligands. The fractional saturation (y) is defined as: (FI9F)/(FI9Ff), where FI is the initial fluorescence of FITC-glu-plg in the absence of
ligand, Ff is the fluorescence of FITC-glu-plg at the maximal ligand concentration used and F is the fluorescence associated with a specific
concentration of ligand.

been shown to bind to a lysine-derivitized sensor chip
surface with multiple dissociation reactions.32 Such multiple dissociation reactions were not surprising since both
plg species have four functional LBSs that are potentially
available for binding. The contours of the sensorgrams,
being obviously different, were suggestive of different
binding mechanisms, as might also have been expected
from the different initial conformations of glu- and lysplg. Global fitting of the glu-plg binding data was accurately described by the two state reaction/conformational
Fibrinolysis & Proteolysis (2000) 0(0), 1–10

change model (Reaction scheme 3) over the entire concentration range of glu-plg used (which spanned its
physiological concentration of 2 M), whereas the lys-plg
binding data was not. In fact, lys-plg was not adequately
described by any of the currently available global fitting
algorithms, at least under the physiological conditions
we used to compare glu- and lys-plg binding.
The two-state reaction/conformational change model
that describes the binding of glu-plg to ␣-enolase suggests that the initial conformation of glu-plg is altered
© Harcourt Publishers Ltd 2000
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after it has been bound by ␣-enolase. In a manner
similar to tranexamic acid or poly-D-lysine, ␣-enolase
produced a concentration-dependent increase in the fluorescence of FITC-glu-plg. An increase in the intrinsic
fluorescence of glu-plg, induced by lysine analogues, is
associated with an open conformation of glu-plg,19 an
observation we made with ␣-enolase. This suggested
that ␣-enolase induces a lysine-dependent conformational change in glu-plg to a more open form. Taken
together, these fluorescence studies validate the twostate reaction/conformational change model as a description of the binding of glu-plg to ␣-enolase.
The association phase kinetics of glu-plg binding to
␣-enolase suggested by the two-state conformational
change model are complex. The relative magnitudes of
ka1 and ka2 for this interaction differ by approximately six
orders of magnitude, indicating that the majority of the
observed binding of glu-plg to ␣-enolase is characterized
by the initial binding reaction. However, ka1, unlike ka2,
increases with decreasing glu-plg concentrations. A
decreasing concentration of glu-plg can also be viewed as
a relative increase in the ␣-enolase abundance which is
paralleled by an increase in ka1. The acceleration in the
initial glu-plg to ␣-enolase binding rate as the relative
concentration of ␣-enolase increases would indicate a
competition reaction. This suggests that during the initial
interaction, an ␣-enolase lysine residue competes with
and displaces a lysine residue of glu-plg from one of its
LBS motifs. This would disrupt the closed, lysine-dependent conformation of glu-plg and induce a conformational change in the zymogen. The second binding event
(ka2) may stabilize this new conformation of glu-plg.
The conformational change of FITC-glu-plg induced
by both tranexamic acid and poly-D-lysine, was cooperative. In contrast, the binding of glu-plg to ␣-enolase
was not co-operative (as opposed to non-co-operative).
This suggests that the multiple kringle LBSs that bind to
the lysine residues of ␣-enolase induce a conformational
change to glu-plg independent of each other. Hence, the
interaction of glu-plg with ␣-enolase would be mediated
by at least two binding events; an initial competition
reaction followed by a second binding event. As a result
of these interactions, glu-plg changes conformation to a
more open form, which is stabilized by a second binding
event (slower dissociation rate). The actual lysine
residues of ␣-enolase(s) involved in the interaction with
glu-plg remain to be determined. There are several possible candidates of which the C-terminal lysine is likely to
play a role.27,28
Taken together, our data suggest that at circulating
levels of 2 M, glu-plg will bind to cell surface receptors
(such as ␣-enolase) and be converted to an open conformation. This finding agrees with the well-documented
observation that binding of small lysine analogues to
© Harcourt Publishers Ltd 2000
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glu-plg changes its conformation,10,12,14,15,18,19,21 which in
turn enhances its activation rate by the plg activators.14,15,21–23 In addition, it has been shown that the lysinedependent binding of glu-plg to fibrin,24,34 cells26,33–36
and isolated receptors33,37,38 including ␣-enolase,27,28
facilitates an increase in the rate of glu-plg activation.
Since the interaction between glu-plg and ␣-enolase is
associated with a change to a more open conformation
of glu-plg, it is suggested that the physiologically important role of cell-surface plg binding proteins39 is to present glu-plg in a form that is essential for its efficient
activation by the plg activators.
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